Yamashima, M., Miyaaki, H., Honda, T., Shibata, H., Miuma, S., Taura, N., & Nakao, K. (2017). Significance of psoas muscle thickness as an indicator of muscle atrophy in patients with hepatocellular carcinoma treated with sorafenib. Mol Clin Oncol.
Citação norma ChicagoYamashima, Mio, Hisamitsu Miyaaki, Takuya Honda, Hidetaka Shibata, Satoshi Miuma, Naota Taura, and Kazuhiko Nakao. "Significance of Psoas Muscle Thickness As an Indicator of Muscle Atrophy in Patients With Hepatocellular Carcinoma Treated With Sorafenib." Mol Clin Oncol 2017.
Citação norma MLAYamashima, Mio, et al. "Significance of Psoas Muscle Thickness As an Indicator of Muscle Atrophy in Patients With Hepatocellular Carcinoma Treated With Sorafenib." Mol Clin Oncol 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.